Book contents
- Seminars in the Psychiatry of Intellectual Disability
- College Seminars Series
- Seminars in the Psychiatry of Intellectual Disability
- Copyright page
- Contents
- Contributors
- Section 1 Understanding Intellectual Disability
- Section 2 Co-morbidity
- Section 3 Psychiatric and Behavioural Disorders
- Chapter 9 Children with Intellectual Disabilities and Psychiatric Problems
- Chapter 10 Adults with Intellectual Disabilities and Psychiatric Disorders
- Chapter 11 Management of Dementia in Intellectual Disability
- Chapter 12 Forensic Psychiatry and Intellectual Disability
- Chapter 13 Psychotherapy in People with Intellectual Disabilities
- Chapter 14 Psychological Treatment of Common Behavioural Disorders
- Chapter 15 Challenging Behaviour and the Use of Pharmacological Interventions
- Section 4 Delivering High-Quality Care
- Index
- References
Chapter 15 - Challenging Behaviour and the Use of Pharmacological Interventions
from Section 3 - Psychiatric and Behavioural Disorders
Published online by Cambridge University Press: 14 January 2019
Book contents
- Seminars in the Psychiatry of Intellectual Disability
- College Seminars Series
- Seminars in the Psychiatry of Intellectual Disability
- Copyright page
- Contents
- Contributors
- Section 1 Understanding Intellectual Disability
- Section 2 Co-morbidity
- Section 3 Psychiatric and Behavioural Disorders
- Chapter 9 Children with Intellectual Disabilities and Psychiatric Problems
- Chapter 10 Adults with Intellectual Disabilities and Psychiatric Disorders
- Chapter 11 Management of Dementia in Intellectual Disability
- Chapter 12 Forensic Psychiatry and Intellectual Disability
- Chapter 13 Psychotherapy in People with Intellectual Disabilities
- Chapter 14 Psychological Treatment of Common Behavioural Disorders
- Chapter 15 Challenging Behaviour and the Use of Pharmacological Interventions
- Section 4 Delivering High-Quality Care
- Index
- References
- Type
- Chapter
- Information
- Seminars in the Psychiatry of Intellectual Disability , pp. 179 - 190Publisher: Cambridge University PressPrint publication year: 2019
References
Bhaumik, S., Branford, D., Barrett, M. & Gangadharan, S. K. (2015) The Frith Prescribing Guidelines for People with Intellectual Disability (3rd edn). Wiley-Blackwell.Google Scholar
Biswas, A. & Bhaumik, S. (2015) Self-injurious behaviour. In The Frith Prescribing Guidelines for People with Intellectual Disability (eds. Bhaumik, S. et al.) (3rd edn), pp. 153–60. Wiley-Blackwell.Google Scholar
Bowring, D., Totsika, V., Hastings, R., Toogood, S. & McMahon, M. (2017) Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability: A total population study. Journal of Intellectual Disability Research, 61(6), 604–17.Google Scholar
Brylewski, J. & Duggan, L. (2004) Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database of Systematic Reviews, 3: CD000377.Google Scholar
Carr, E. G. (1977) The motivation of self-injurious behaviour: a review of some hypothesis. Psychological Bulletin, 84(4), 800–16Google Scholar
Deb, S., Clarke, D. & Unwin, G. (2006) Using medications to manage behavioural problems among adults with a learning disability. DATABID. Available at: www.LD-Medication.bham.ac.uk [accessed 2 September 2018]Google Scholar
Deb, S., Kwork, H., Bertelli, M. et al. (2009) International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities. World Psychiatry, 8, 181–6.Google Scholar
Devapriam, J., Rosenbach, A. & Alexander, R. (2015) In-patient services for people with intellectual disability and mental health or behavioural difficulties. BJPsych Advances, 21(2), 116–23.Google Scholar
Department of Health (2012a) Department of Health Review: Winterbourne View Hospital Interim Report. Department of Health.Google Scholar
Department of Health (2012b) Transforming Care: A National Response to Winterbourne View Hospital: Department of Health Review Final Report. Department of Health.Google Scholar
Felce, D., Kerr, M. & Hastings, R. P. (2009) A general practice based study of the relationship between indicators of mental illness and challenging behaviour among adults with intellectual disabilities. Journal of Intellectual Disability Research, 53(3), 243–54.Google Scholar
Gagiano, C., Read, S., Thorpe, L., Eerdekens, M. & Van Hove, I. (2005) Short- and long-term efficacy and safety of risperidone in adults with disruptive behaviour disorders. Psychopharmacology, 179(3), 629–36.Google Scholar
General Medical Council (2013) Good Practice in Prescribing and Managing Medicines and Devices. General Medical Council.Google Scholar
Glover, G. Bernard, S. Branford, D. et al. (2014) Use of medication for challenging behaviour in people with intellectual disability. British Journal of Psychiatry, 205: 6–7.Google Scholar
Hastings, R. P., Allen, A., Baker, P. et al. (2013) A conceptual framework for understanding why challenging behaviours occur in people with developmental disabilities. International Journal of Positive Behavioural Support, 3(2), 5–13.Google Scholar
Holland, T. (2011) The art of formulation. Learning Disability Psychiatry – Newsletter of the Faculty of Learning Disability, RCPsych, 13(2).Google Scholar
Kalachnik, J. E., Leventhal, B. L., James, D. H. et al. (1998) Guidelines for the Use of psychotropic medication. In Psychotropic Medication and Developmental Disabilities: The International Consensus Handbook (eds. Reiss, S. & Aman, M.), pp. 45–72. Ohio State University.Google Scholar
Matson, J. L., Bamburg, J., Mayville, E. A. et al. (2000) Psychopharmacology and mental retardation – A 10 year review (1992–1999). Research in Developmental Disabilities, 21: 263–96.Google Scholar
Matson, J. L., Tureck, K. & Riske, R. (2012) The Questions About Behavioural Function (QABF): Current status as a method of functional assessment. Research in Developmental Disabilities, 33(2), 630–4.CrossRefGoogle ScholarPubMed
Molyneux, B., Emerson, E. & Caine, A. (1999) Prescription of psychotropic medication to people with intellectual disabilities in primary healthcare settings. Journal of Applied Research in Intellectual Disability, 12: 46–57.Google Scholar
National Collaborating Centre for Mental Health (2012) Autism: The NICE Guideline on Recognition, Referral, Diagnosis and Management of Adults on the Autism Spectrum (National Clinical Guideline Number 142). British Psychological Society & Royal College of PsychiatristsGoogle Scholar
NHS England (2015) The Use of Medications in People with Learning Disabilities. NHS England. Available at: www.england.nhs.uk/2015/07/14/urgent-pledge [accessed 2 September 2018]Google Scholar
NICE (2015) Challenging Behaviour and Learning Disabilities: Prevention and interventions for People with Learning Disabilities Whose Behaviour Challenges (NG11). NICE. Available at: www.nice.org.uk/guidance/ng11 [accessed 2 September 2018]Google Scholar
NICE (2016) Mental Health Problems in People with Learning Disabilities: Prevention, Assessment and Management (NG54). NICE. Available at: www.nice.org.uk/Guidance/NG54 [accessed 2 September 2018]Google Scholar
Paton, C., Bhatti, S., Purandare, K., Roy, A. & Barnes, T. (2016) Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: A cross-sectional audit of clinical practice. British Medical Journal Open, 6(12), e013116.Google Scholar
Public Health England (2015) Prescribing of Psychotropic Drugs to People with Learning Disabilities and or Autism by General Practitioners in England. Public Health England.Google Scholar
Royal College of Psychiatrists (2016) Psychotropic Drug Prescribing for People with Intellectual Disability, Mental Health Problems and/or Behaviours That Challenge: Practice Guidelines. FR/ID/09. Royal College of Psychiatrists. Available at: www.rcpsych.ac.uk/pdf/FR_ID_09_for_website.pdf [accessed 2 September 2018]Google Scholar
Royal College of Psychiatrists, British Psychological Society, Royal College of Speech and Language Therapists (2007) Challenging Behaviour: A Unified Approach (CR144). Royal College of Psychiatrists. Available at: www.rcpsych.ac.uk/files/pdfversion/cr144.pdf [accessed 2 September 2018]Google Scholar
Rush, A. J. & Frances, A. (2000) Expert Consensus Guidelines Series: treatment of psychiatric and behavioural problems in mental retardation. American Journal of Mental Retardation, 105, 159–227.Google Scholar
Sheehan, R., Hassiotis, A., Walters, K., Osborn, D., Strydom, A. & Horsfall, L. (2015) Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. British Medical Journal, 351, h4326.Google Scholar
Tsiouris, J. A. (2010) Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities – Treatment or mistreatment? Journal of Intellectual Disability Research, 54, 1–16.Google Scholar
Tyrer, P., Oliver-Africano, P.., Romeo, R. et al. (2009) Neuroleptics in the treatment of aggressive challenging behaviour that challenges for people with intellectual disabilities: a randomised controlled trial (NACHBID). Health Technology Assessment, 13: iii–iv, ix–xi, 1–54.Google Scholar
Unwin, G. L. & Deb, S. (2008) The use of medication for the management of behaviour problems among adults with intellectual disability: A clinician’s consensus survey. American Journal on Mental Retardation, 113, 19–31.Google Scholar
Unwin, G. L. & Deb, S. (2011) Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: A systematic review. Research in Developmental Disabilities, 32, 2121–33.Google Scholar
Xeniditis, K., Russell, A. & Murphy, D. (2001) Management of people with challenging behaviour. Advances in Psychiatric Treatment, 7, 109–16.Google Scholar